Research Article
Evaluation of Susceptibility of the Human Pathogen Helicobacter pylori to the Antibiotic Capreomycin
Table 1
Antimicrobial susceptibility testing of H. pylori by agar dilution and E-test.
| | | EUCAST breakpoints (μg/mL) | MIC (μg/mL) | Resistance rate (%) | | Agar dilution | E-Test | Agar dilution | E-Test |
| | Amoxicillin (AMX) | >0.12 | 0.064–2 | 0.125–16 | 0 | 0 | | Capreomycin (CAP) | NA | 0.25–64 | NA | NA | NA | | Clarithromycin (CLA) | >0.5 | 0.25–4 | 0.25–2 | 0 | 0 | | Metronidazole (MTZ) | >8 | 2–64 | 2–64 | 20 | 20 | | Levofloxacin (LEV) | >1 | 0.015–8 | 0.015–8 | 20 | 20 |
|
|
H. pylori strains MIC was greater than the breakpoint concentration. NA = nonapplicable. |
